Clinical significance of receptor shedding-platelet GPVI as an emerging diagnostic and therapeutic tool

References

• Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002;8:1227–1234.
   PubMed Web of Science ®Google Scholar
• Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378–3384
   PubMed Web of Science ®Google Scholar
• von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007;100:27–40.
   PubMed Web of Science ®Google Scholar
• Ginsberg MH, Loftus J, Plow EF. Platelets and the adhesion receptor superfamily. Prog Clin Biol Res 1988;283:171–195.
   PubMedGoogle Scholar
• Nieswandt B, Pleines I, Bender M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost 2011;9:92–104.
   PubMed Web of Science ®Google Scholar
• Andrews RK, Karunakaran D, Gardiner EE, Berndt MC. Platelet receptor proteolysis: a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 2007;27:1511–1520.
   PubMed Web of Science ®Google Scholar
• Qiao JL, Shen Y, Gardiner EE, Andrews RK. Proteolysis of platelet receptors in humans and other species. Biol Chem 2010;391:893–900.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood 2003;102:449–461.
   PubMed Web of Science ®Google Scholar
• Dutting S, Bender M, Nieswandt B. Platelet GPVI: a target for antithrombotic therapy? Trends Pharmacol Sci 2012;33:583–590.
   PubMed Web of Science ®Google Scholar
• Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999;274:29019–29024.
   PubMed Web of Science ®Google Scholar
• Jandrot-Perrus M, Busfield S, Lagrue AH, Xiong X, Debili N, Chickering T, Le Couedic JP, Goodearl A, Dussault B, Fraser C, et al. Cloning, characterisation, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 2000;96:1798–1807.
   PubMed Web of Science ®Google Scholar
• Miura Y, Takahashi T, Jung SM, Moroi M. Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen. J Biol Chem 2002;277:46197–46204.
   Google Scholar
• Mammadova-Bach E, Ollivier V, Loyau S, Schaff M, Dumont B, Favier R, Freyburger G, Latger-Cannard V, Nieswandt B, Gachet C, et al. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood. 2015;126:683–691.
   PubMed Web of Science ®Google Scholar
• Zahid M, Mangin P, Loyau S, Hechler B, Billiald P, Gachet C, Jandrot-Perrus M. The future of glycoprotein VI as an antithrombotic target. J Thromb Haemost 2012;10:2418–2427.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Krämer BF, Seizer P, Fateh-Moghadam S, Gawaz M, Lindemann S. Diagnostic and therapeutic potentials of platelet glycoprotein VI. Semin Thromb Haemost 2010;36:203–211.
   PubMed Web of Science ®Google Scholar
• Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012;120:e73–e82.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Andrews RK. Platelet receptor expression and shedding: glycoprotein Ib-IX-V and glycoprotein VI. Transfus Med Rev 2014;28:56–60.
   PubMed Web of Science ®Google Scholar
• Inoue O, Suzuki-Inoue K, McCarty OJ, Moroi M, Ruggeri ZM, Kunicki TJ, Ozaki Y, Watson SP. Laminin stimulates spreading of platelets through integrin alpha6beta1-dependent activation of GPVI. Blood 2006;107:1405–1412.
   PubMed Web of Science ®Google Scholar
• Farndale RW, Sixma JJ, Barnes MJ, de Groot PG. The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2004;2:561–573.
   PubMed Web of Science ®Google Scholar
• Polgár J, Clemetson JM, Kehrel BE, Wiedemann M, Magnenat EM, Wells TN, Clemetson KJ. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem 1997;272:13576–13583.
   PubMed Web of Science ®Google Scholar
• Andrews RK, Gardiner EE, Asazuma N, Berlanga O, Tulasne D, Nieswandt B, Smith AI, Berndt MC, Watson SP. A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI.J Biol Chem 2001;276:28092–28097.
   Web of Science ®Google Scholar
• Loyau S, Dumont B, Ollivier V, Boulaftali Y, Feldman L, Ajzenberg N, Jandrot-Perrus M. Platelet glycoprotein VI dimerisation, an active process inducing receptor competence, is an indicator of platelet reactivity. Arterioscler Thromb Vasc Biol 2012;32:778–785.
   PubMed Web of Science ®Google Scholar
• Jung SM, Moroi M, Soejima K, Nakagaki T, Miura Y, Berndt MC, Gardiner EE, Howes JM, Pugh N, Bihan D, et al. Constitutive dimerisation of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood. J Biol Chem 2012;287:30000–30013.
   PubMed Web of Science ®Google Scholar
• Arthur JF, Shen Y, Kahn ML, Berndt MC, Andrews RK, Gardiner EE. Ligand binding rapidly induces disulfide-dependent dimerization of glycoprotein VI on the platelet plasma membrane. J Biol Chem 2007;282:30434–30441.
   PubMed Web of Science ®Google Scholar
• Chen H, Locke D, Liu Y, Liu C, Kahn ML. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density dependent fashion. J Biol Chem 2002;277:3011–3019.
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Rabie T, Strehl A, Piffath C, Prostredna M, Wagner D, Nieswandt B. GPVI down-regulation in murine platelets through metalloproteinase-dependent shedding. Thromb Haemost 2004;91:951–958.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Arthur JF, Kahn ML, Berndt MC, Andrews RK. Regulation of platelet membrane levels of glycoprotein VI by a platelet derived metalloproteinase. Blood 2004;104:3611–3617.
   PubMed Web of Science ®Google Scholar
• Stephens G, Yan Y, Jandrot-Perrus M, Villeval JL, Clemetson KJ, Phillips DR. Platelet activation induces metalloproteinase-dependent GPVI cleavage to down-regulate platelet reactivity to collagen. Blood 2005;105:186–191.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Arthur JF, Berndt MC, Andrews RK. Role of calmodulin in platelet receptor function. Curr Med Chem Cardiovasc Hematol Agents 2005;3:283–287.
   PubMedGoogle Scholar
• Brocker CN, Vasiliou V, Nebert DW. Evolutionary divergence and functions of the ADAM and ADAMTS gene families. Hum. Genomics 2009;4:43–55.
   PubMedGoogle Scholar
• Wijeyewickrema LC, Berndt MC, Andrews RK. Snake venom probes of platelet adhesion receptors and their ligands. Toxicon 2005;45:1051–1061.
   PubMed Web of Science ®Google Scholar
• Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E, Blobel CP, Himanen JP, Lackmann M, et al. ADAM meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 2005;123:291–304.
   PubMed Web of Science ®Google Scholar
• Murphy G. Regulation of the proteolytic disintegrin metalloproteinases, the ‘sheddases’. Semin Cell Dev Biol 2009;20:138–145.
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Piffath CL, Cheng G, Dole VS, Zhang Y, von Andrian UH, Wagner DD. Tumor necrosis factor- α -converting enzyme (ADAM17) mediates GPIb α shedding from platelets in vitro and in vivo. Circ. Res 2004;95:677–683.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Berndt MC. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 2007;5:1530–1537.
   PubMed Web of Science ®Google Scholar
• Al-Tamimi M, Mu FT, Arthur JF, Shen Y, Moroi M, Berndt MC, Andrews RK, Gardiner EE. Anti glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcγRIIa and induce GPVI ectodomain shedding. Platelets 2009;20:75–82.
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Burger PC, Piffath CL, Hoffmeister KM, Hartwig JH, Nieswandt B, Wagner DD. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro - aged or -injured mouse platelets. Blood 2003;102:4229–4235.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Karunakaran D, Arthur JF, Mu FT, Powell MS, Baker RI, Hogarth PM, Kahn ML, Andrews RK, Berndt MC. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAMizing Fc γRIIa. Blood 2008;111:165–174.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Al-Tamimi M, Mu FT, Karunakaran D, Thom JY, Moroi M, Andrews RK, Berndt MC, Baker RI. Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura. J Thromb Haemost 2008;6:1175–1182.
   PubMed Web of Science ®Google Scholar
• Al-Tamimi M, Tan CW, Qiao J, Pennings GJ, Javadzadegan A, Yong AS, Arthur JF, Davis AK, Jing J, Mu FT, et al. Pathologic shear triggers shedding of vascular receptors: a novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vessels. Blood 2012;119:4311–4320.
   PubMed Web of Science ®Google Scholar
• Takayama H, Hosaka Y, Nakayama K, Shirakawa K, Naitoh K, Matsusue T, Shinozaki M, Honda M, Yatagai Y, Kawahara T, et al. A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor γ -chain complex. J Clin Invest 2008;118:1785–1795.
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987;69:1712–1720.
   PubMed Web of Science ®Google Scholar
• Alberio L, Friese P, Clemetson KJ, Dale GL. Collagen response and glycoprotein VI function decline progressively as canine platelets age in vivo. Thromb Haemost 2002;88:510–516.
   PubMed Web of Science ®Google Scholar
• Al-Tamimi M, Mu FT, Moroi M, Gardiner EE, Berndt MC, Andrews RK. Measuring soluble platelet glycoprotein VI in human plasma by ELISA. Platelets 2009;20:143–149.
   PubMed Web of Science ®Google Scholar
• Aleil B, Meyer N, Wolff V, Kientz D, Wiesel ML, Gachet C, Cazenave JP, Lanza F. Plasma glycoprotein V levels in the general population: normal distribution, associated parameters and implications for clinical studies. Thromb. Haemost 2006;96:505–511.
   PubMed Web of Science ®Google Scholar
• Steinberg MH, Kelton JG, Coller BS. Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders. N. Engl. J. Med 1987;317:1037–1042.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Thom JY, Al-Tamimi M, Hughes A, Berndt MC, Andrews RK, Baker RI. Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura. Br. J. Haematol 2010;149:625–628.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Lindemann S, Ehlers R, Seizer P, Daub K, Langer H, Schonberger T, Kremmer E, Siegel-Axel D, May AE, et al. Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome. Eur Heart J 2006;27:2165–2169.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Stellos K, Weig HJ, Geisler T, Seizer P, Kremmer E, Pötz O, Joos T, May AE, Lindemann S, et al. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS). Basic Res Cardiol 2009;104:352–357.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Haap M, Stellos K, Geisler T, Seizer P, Kremmer E, Overkamp D, Gawaz M. Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain. Thromb Res 2010; 125: e184–e189.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Stellos K, Geisler T, Lindemann S, May AE, Gawaz M. Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease. Clin Res Cardiol 2010;99:227–233.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Stellos K, Geisler T, Kremmer E, Seizer P, May AE, Lindemann S, Gawaz M. Glycoprotein VI for diagnosis of acute coronary syndrome when ECG is ambiguous. Int J Cardiol 2011;149:164–168.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Geisler T, Stellos K, Langer H, Daub K, Kremmer E, Seizer P, May AE, Lindemann S, Gawaz M. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Am Heart J 2008;156:193–200.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Stellos K, Geisler T, Kremmer E, Seizer P, May AE, Lindemann S, Melms A, Luft A, Gawaz M. Expression of platelet glycoprotein VI is associated with transient ischaemic attack and stroke. Eur J Neurol 2010;17:111–117.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Pötz O, Kremmer E, Geisler T, Seizer P, Puntmann VO, Phinikaridou A, Chiribiri A, Nagel E, Botnar RM, et al. Sandwich immunoassay for soluble glycoprotein VI in patients with symptomatic coronary artery disease. Clin Chem 2011;57:898–904.
   PubMed Web of Science ®Google Scholar
• Al-Tamimi M, Gardiner EE, Thom JY, Shen Y, Cooper MN, Hankey GJ, Berndt MC, Baker RI, Andrews RK. Soluble glycoprotein VI is raised in the plasma of patients with acute ischaemic stroke. Stroke 2011;42:498–500.
   PubMed Web of Science ®Google Scholar
• Wurster T, Poetz O, Stellos K, Kremmer E, Melms A, Schuster A, Nagel E, Joos T, Gawaz M, Bigalke B. Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischaemic stroke. Platelets 2013;24:560–565.
   PubMed Web of Science ®Google Scholar
• Cabeza N, Li Z, Schulz C, Kremmer E, Massberg S, Bültmann A, Gawaz M. Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 2004;53:2117–2121.
   PubMed Web of Science ®Google Scholar
• Al-Tamimi M, Grigoriadis G, Tran H, Paul E, Servadei P, Berndt MC, Gardiner EE, Andrews RK. Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa. Blood 2011;117:3912–3920.
   PubMed Web of Science ®Google Scholar
• Bender M, Hofmann S, Stegner D, Chalaris A, Bösl M, Braun A, Scheller J, Rose-John S, Nieswandt B. Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 2010;116:3347–3355.
   PubMed Web of Science ®Google Scholar
• Nurden P, Tandon N, Takizawa H, Couzi L, Morel D, Fiore M, Pillois X, Loyau S, Jandrot-Perrus M, Nurden AT. An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis. J Thromb Haemost 2009;7:1541–1549.
   PubMed Web of Science ®Google Scholar
• Laske C, Leyhe T, Stransky E, Eschweiler GW, Bueltmann A, Langer H, Stellos K, Gawaz M. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer’s disease. J Psych Res 2008;42:746–751.
   Web of Science ®Google Scholar
• Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657–671.
   PubMed Web of Science ®Google Scholar
• Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003;108:1772–1778.
   PubMed Web of Science ®Google Scholar
• Langer HF, Haubner R, Pichler BJ, Gawaz M. Radionuclide imaging: a molecular key to the atherosclerotic plaque. J Am Coll Cardiol 2008;52:1–12.
   PubMed Web of Science ®Google Scholar
• Massberg S, Konrad I, Bültmann A, Schulz C, Münch G, Peluso M, Lorenz M, Schneider S, Besta F, Müller I, et al. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 2004;18:397–399.
   PubMedGoogle Scholar
• Schulz C, Penz S, Hoffmann C, Langer H, Gillitzer A, Schneider S, Brandl R, Seidl S, Massberg S, Pichler B, et al. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 2008;103:356–367.
   PubMed Web of Science ®Google Scholar
• Schonberger T, Siegel-Axel D, Bussl R, Richter S, Judenhofer MS, Haubner R, Reischl G, Klingel K, Münch G, Seizer P, et al. The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- mice. Cardiovasc Res 2008;80:131–137.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Phinikaridou A, Andia ME, Cooper MS, Schuster A, Schönberger T, Griessinger CM, Wurster T, Onthank D, Ungerer M, et al. PET/CT and MR Imaging in a Murine Model of Progressive Atherosclerosis Using 64Cu-labelled Glycoprotein VI-Fc. Circ Cardiovasc Imaging 2013;6:957–964.
   PubMed Web of Science ®Google Scholar
• Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev 2010;110:2858–2902.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Lindemann S, Schönberger T, Pohlmeyer I, Chiribiri A, Schuster A, Botnar RM, Griessinger CM, Pichler BJ, Gawaz M. Ex vivo imaging of injured arteries in rabbits using fluorescence-labelled glycoprotein VI-Fc. Platelets 2012;23:1–6.
   PubMed Web of Science ®Google Scholar
• Bigalke B, Pohlmeyer I, Schönberger T, Griessinger CM, Ungerer M, Botnar RM, Pichler BJ, Gawaz M. Imaging of injured and atherosclerotic arteries in mice using fluorescence-labelled glycoprotein VI-Fc. Eur J Radiol 2011; 79: e63–e69.
   PubMed Web of Science ®Google Scholar
• Kaufmann BA, Sanders JM, Davis C, Xie A, Aldred P, Sarembock IJ, Lindner JR. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 2007;116:276–84.
   PubMed Web of Science ®Google Scholar
• Khanicheh E, Mitterhuber M, Xu L, Haeuselmann SP, Kuster GM, Kaufmann BA. Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis. PLoS One 2013;8:e58761.
   PubMed Web of Science ®Google Scholar
• Khanicheh E, Qi Y, Xie A, Mitterhuber M, Xu L, Mochizuki M, Daali Y, Jaquet V, Krause KH, Ruggeri ZM, et al. Molecular Imaging Reveals Rapid Reduction of Endothelial Activation in Early Atherosclerosis With Apocynin Independent of Antioxidative Properties. Arterioscler Thromb Vasc Biol 2013;33:2187–92.
   PubMed Web of Science ®Google Scholar
• Liu Y, Davidson BP, Yue Q, Belcik T, Xie A, Inaba Y, McCarty OJ, Tormoen GW, Zhao Y, Ruggeri ZM, et al. Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. Circ Cardiovasc Imaging 2013;6:74–82.
   PubMed Web of Science ®Google Scholar
• Wang X, Hagemeyer CE, Hohmann JD, Leitner E, Armstrong PC, Jia F, Olschewski M, Needles A, Peter K, Ahrens I. Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice. Circulation 2012;125:3117–26.
   PubMed Web of Science ®Google Scholar
• Metzger K, Vogel S, Chatterjee M, Borst O, Seizer P, Schönberger T, Geisler T, Lang F, Langer H, Rheinlaender J, et al. High-frequency ultrasound-guided disruption of glycoprotein VI-targeted microbubbles targets atheroprogressison in mice. Biomaterials 2015;36:80–89.
   PubMed Web of Science ®Google Scholar
• Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989;84:1440–1445.
   PubMed Web of Science ®Google Scholar
• Matus V, Valenzuela G, Sáez CG, Hidalgo P, Lagos M, Aranda E, Panes O, Pereira J, Pillois X, Nurden AT, et al. An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in four Chilean families. J Thromb Haemost 2013;11:1751–1759.
   PubMed Web of Science ®Google Scholar
• Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 2003;102:1701–1707.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Bergmeier W, Schulte V, Rackebrandt K, Gessner JE, Zirngibl H. Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRgamma chain. J Biol Chem 2000;275:23998–24002.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Schulte V, Bergmeier W, Mokhtari-Nejad R, Rackebrandt K, Cazenave JP, Ohlmann P, Gachet C, Zirngibl H. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med 2001;193:459–469.
   PubMed Web of Science ®Google Scholar
• Cosemans JM, Kuijpers MJ, Lecut C, Loubele ST, Heeneman S, Jandrot-Perrus M, Heemskerk JW. Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis 2005;181:19–27.
   PubMed Web of Science ®Google Scholar
• Reininger AJ, Bernlochner I, Penz SM, Ravanat C, Smethurst P, Farndale RW, Gachet C, Brandl R, Siess W. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. J Am Coll Cardiol 2010;55:1147–1158.
   PubMed Web of Science ®Google Scholar
• Li H, Lockyer S, Concepcion A, Gong X, Takizawa H, Guertin M, Matsumoto Y, Kambayashi J, Tandon NN, Liu Y. The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats. Arterioscler Thromb Vasc Biol 2007;27:1199–1205.
   PubMed Web of Science ®Google Scholar
• Mangin PH, Tang C, Bourdon C, Loyau S, Freund M, Hechler B, Gachet C, Jandrot-Perrus M. A humanized glycoprotein VI (GPVI) mouse model to assess the antithrombotic efficacies of anti-GPVI agents. J Pharm Exp Ther 2012;341:156–163.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Takizawa H, Gong X, Le S, Lockyer S, Okuyama K, Tanaka M, Yoshitake M, Tandon NN, Kambayashi J. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunisation. Thromb Res 2007;119:319–329.
   PubMed Web of Science ®Google Scholar
• Andrews RK, Arthur JF, Gardiner EE. Targeting GPVI as a novel antithrombotic strategy. J Blood Med 2014;5:59–68.
   PubMedGoogle Scholar
• Walker A, Pugh N, Garner SF, Stephens J, Maddox B, Ouwehand WH, Farndale RW, Steward M, Bloodomics Consortium. Bloodomics Consortium. Single domain antibodies against the collagen signaling receptor glycoprotein VI are inhibitors of collagen induced thrombus formation. Platelets 2009;20:268–276.
   Google Scholar
• Muzard J, Bouabdelli M, Zahid M, Ollivier V, Lacapère JJ, Jandrot-Perrus M, Billiald P. Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro. FEBS J 2009;276:4207–4222.
   PubMed Web of Science ®Google Scholar
• Ohlmann P, Hechler B, Ravanat C, Loyau S, Herrenschmidt N, Wanert F, Jandrot-Perrus M, Gachet C. Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression. J Thromb Haemost 2008;6:1003–1011.
   PubMed Web of Science ®Google Scholar
• Bultmann A, Li Z, Wagner S, Peluso M, Schönberger T, Weis C, Konrad I, Stellos K, Massberg S, Nieswandt B, et al. Impact of glycoprotein VI and platelet adhesion on atherosclerosis – a possible role of fibronectin. J Mol Cell Cardiol 2010;49:532–542.
   PubMed Web of Science ®Google Scholar
• Ungerer M, Li Z, Baumgartner C, Goebel S, Vogelmann J, Holthoff HP, Gawaz M, Münch G. The GPVI – Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times. PloS One 2013;8:e71193.
   PubMed Web of Science ®Google Scholar
• Goebel S, Li Z, Vogelmann J, Holthoff HP, Degen H, Hermann DM, Gawaz M, Ungerer M, Münch G. The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke. PloS One 2013;8:e66960.
   PubMed Web of Science ®Google Scholar
• Schonberger T, Ziegler M, Borst O, Konrad I, Nieswandt B, Massberg S, Ochmann C, Jürgens T, Seizer P, Langer H, et al. The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischaemia in mice. Am J Physiol Cell Physiol 2012;303:C757–C766.
   PubMed Web of Science ®Google Scholar
• Bültmann A, Herdeg C, Li Z, Münch G, Baumgartner C, Langer H, Kremmer E, Geisler T, May A, Ungerer M, et al. Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo. Thromb Haemost 2006;95763–95766.
   Google Scholar